The Cooper's ROE % for the quarter that ended in Jan. 2024 was 4.26%. The Cooper's PB Ratio for the quarter that ended in Jan. 2024 was 2.41.
The Cooper's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2024 was 1.77%.
The Cooper ROE % Adjusted to Book Value Historical Data
The historical data trend for The Cooper's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Cooper's ROE % Adjusted to Book Value
For the Medical Instruments & Supplies subindustry, The Cooper's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where The Cooper's ROE % Adjusted to Book Value falls into.
The Cooper ROE % Adjusted to Book Value Calculation
The Cooper's ROE % Adjusted to Book Value for the fiscal year that ended in Oct. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cooper ROE % Adjusted to Book Value Related Terms
Thank you for viewing the detailed overview of The Cooper's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COO has been successfully added to your 